Correlation Between Cingulate Warrants and Anebulo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Cingulate Warrants and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and Anebulo Pharmaceuticals.
Diversification Opportunities for Cingulate Warrants and Anebulo Pharmaceuticals
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Cingulate and Anebulo is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and Anebulo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cingulate Warrants and Anebulo Pharmaceuticals
Assuming the 90 days horizon Cingulate Warrants is expected to generate 5.0 times more return on investment than Anebulo Pharmaceuticals. However, Cingulate Warrants is 5.0 times more volatile than Anebulo Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Anebulo Pharmaceuticals is currently generating about -0.07 per unit of risk. If you would invest 4.49 in Cingulate Warrants on September 12, 2024 and sell it today you would lose (0.86) from holding Cingulate Warrants or give up 19.15% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 90.91% |
Values | Daily Returns |
Cingulate Warrants vs. Anebulo Pharmaceuticals
Performance |
Timeline |
Cingulate Warrants |
Anebulo Pharmaceuticals |
Cingulate Warrants and Anebulo Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cingulate Warrants and Anebulo Pharmaceuticals
The main advantage of trading using opposite Cingulate Warrants and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.Cingulate Warrants vs. Equillium | Cingulate Warrants vs. DiaMedica Therapeutics | Cingulate Warrants vs. Valneva SE ADR | Cingulate Warrants vs. Vivani Medical |
Anebulo Pharmaceuticals vs. Adagene | Anebulo Pharmaceuticals vs. Acrivon Therapeutics, Common | Anebulo Pharmaceuticals vs. AnaptysBio | Anebulo Pharmaceuticals vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |